The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19-Reference-Cited by-同舟云学术

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

Published:2021-02-15 Issue:7 Volume:58 Page:831-843
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Shah Harsh,Khan Md Shahjalal Hossain,Dhurandhar Nikhil V.,Hegde Vijay^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00592-020-01636-z.pdf

Reference153 articles.

1. Center for Systems Science and Engineering (CSSE) at John Hopkins University (JHU) https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed Aug 5 2020

2. Ryan DH, Ravussin E, Heymsfield S (2020) COVID 19 and the patient with obesity–the editors speak out. Obesity. https://doi.org/10.1002/oby.22808

3. Feng Y, Ling Y, Bai T et al (2020) COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 201(11):1380–1388. https://doi.org/10.1164/rccm.202002-0445OC

4. Chen T, Wu D, Chen H et al (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. https://doi.org/10.1136/bmj.m1091

5. Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells;Viruses;2024-08-02

2. Prevalence and outcomes of atrial fibrillation in patients hospitalized with COVID-19;Current Medical Research and Opinion;2024-07-26

3. Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial;Scientific Reports;2024-05-14

4. Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021;PLOS ONE;2024-04-17

5. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID;npj Science of Food;2024-03-30